X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2519) 2519
Magazine Article (5) 5
Book Chapter (3) 3
Conference Proceeding (2) 2
Book / eBook (1) 1
Government Document (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2071) 2071
science & technology (1864) 1864
life sciences & biomedicine (1808) 1808
male (1255) 1255
morpholines - therapeutic use (1165) 1165
female (1112) 1112
morpholines - adverse effects (936) 936
middle aged (757) 757
morpholines - administration & dosage (733) 733
morpholines - pharmacology (732) 732
adult (683) 683
rivaroxaban (672) 672
aged (629) 629
animals (622) 622
pharmacology & pharmacy (461) 461
treatment outcome (452) 452
thiophenes - adverse effects (415) 415
anticoagulants - adverse effects (393) 393
thiophenes - therapeutic use (383) 383
administration, oral (355) 355
oncology (330) 330
anticoagulants - therapeutic use (325) 325
dabigatran (309) 309
thiophenes - administration & dosage (274) 274
double-blind method (272) 272
beta-alanine - analogs & derivatives (260) 260
dose-response relationship, drug (248) 248
neurosciences & neurology (245) 245
antiemetics - therapeutic use (242) 242
vomiting - chemically induced (240) 240
anticoagulants - administration & dosage (238) 238
nausea - chemically induced (237) 237
aprepitant (231) 231
cardiovascular system & cardiology (231) 231
rats (229) 229
medicine & public health (227) 227
abridged index medicus (222) 222
anticoagulants (222) 222
neurosciences (214) 214
analysis (202) 202
morpholines - pharmacokinetics (201) 201
mice (197) 197
vomiting - prevention & control (195) 195
aged, 80 and over (194) 194
antineoplastic agents - adverse effects (192) 192
benzimidazoles - adverse effects (191) 191
benzimidazoles - therapeutic use (190) 190
cancer (187) 187
drug therapy (187) 187
hemorrhage - chemically induced (187) 187
drug therapy, combination (186) 186
chemotherapy (182) 182
nausea - prevention & control (182) 182
time factors (179) 179
atrial fibrillation - drug therapy (177) 177
care and treatment (173) 173
nausea (170) 170
atrial fibrillation (169) 169
chromones - pharmacology (167) 167
adolescent (164) 164
risk factors (163) 163
stroke - prevention & control (162) 162
pyridones - therapeutic use (160) 160
hematology (159) 159
factor xa inhibitors (157) 157
pyrazoles - therapeutic use (157) 157
psychiatry (153) 153
beta-alanine - therapeutic use (146) 146
research (146) 146
beta-alanine - adverse effects (144) 144
cardiac & cardiovascular systems (144) 144
drug interactions (144) 144
atrial fibrillation - complications (140) 140
general & internal medicine (137) 137
young adult (136) 136
benzimidazoles - administration & dosage (135) 135
drug administration schedule (135) 135
clinical trials as topic (134) 134
prevention (132) 132
clinical trials (131) 131
medicine, general & internal (126) 126
prospective studies (125) 125
dosage and administration (123) 123
health aspects (123) 123
pyridones - adverse effects (122) 122
vomiting (122) 122
pyrazoles - adverse effects (120) 120
disease models, animal (118) 118
signal transduction - drug effects (118) 118
randomized controlled trials as topic (117) 117
peripheral vascular disease (116) 116
urea - analogs & derivatives (114) 114
venous thromboembolism - prevention & control (114) 114
phosphatidylinositol 3-kinases - antagonists & inhibitors (113) 113
warfarin - therapeutic use (112) 112
neoplasms - drug therapy (111) 111
internal medicine (109) 109
antineoplastic combined chemotherapy protocols - adverse effects (107) 107
reboxetine (107) 107
warfarin - adverse effects (107) 107
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2346) 2346
German (54) 54
Japanese (51) 51
French (46) 46
Russian (24) 24
Spanish (17) 17
Chinese (16) 16
Italian (12) 12
Czech (7) 7
Hungarian (6) 6
Polish (4) 4
Danish (3) 3
Dutch (3) 3
Finnish (2) 2
Norwegian (2) 2
Portuguese (2) 2
Swedish (2) 2
Korean (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 06/2008, Volume 358, Issue 26, pp. 2765 - 2775
Rivaroxaban is an orally administered direct inhibitor of factor Xa. As compared with enoxaparin, rivaroxaban was more effective in preventing venous... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Pulmonary Embolism - prevention & control | Venous Thromboembolism - mortality | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Anticoagulants - therapeutic use | Arthroplasty, Replacement, Hip | Anticoagulants - adverse effects | Venous Thrombosis - epidemiology | Adolescent | Aged | Enoxaparin | Dosage and administration | Blood coagulation factors | Comparative analysis | Health aspects | Hip joint | Clinical trials | Comparative studies | Joint surgery | Drug therapy | Clinical outcomes | Blood clots | Index Medicus | Abridged Index Medicus | Enoxaparin/adverse effects/therapeutic use | Venous Thrombosis/epidemiology/prevention & control | Thiophenes/adverse effects/therapeutic use | Arthroplasty | Replacement | Kirurgi | Hip | Morpholines/adverse effects/therapeutic use | 80 and over | Surgery | Anticoagulants/adverse effects/therapeutic use | Venous Thromboembolism/mortality/prevention & control | Factor Xa/antagonists & inhibitors | Pulmonary Embolism/epidemiology/prevention & control
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 03/2012, Volume 107, Issue 3, pp. 584 - 589
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2014, Volume 179, pp. 279 - 287
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2012, Volume 366, Issue 14, pp. 1287 - 1297
Journal Article
PloS one, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, pp. e0198448 - e0198448
The use of pesticides exposes humans to numerous harmful molecules. Exposure in early-life may be responsible for adverse effects in later life... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Glycine - analogs & derivatives | Glycine - adverse effects | Oxidative Stress | Humans | Proton Magnetic Resonance Spectroscopy | Female | Neonicotinoids - adverse effects | France | Morpholines - adverse effects | Disease Models, Animal | Animals, Newborn | Organophosphorus Compounds - adverse effects | Rats | Nitro Compounds - adverse effects | Toluidines - adverse effects | Chlormequat - adverse effects | Metabolomics - methods | Environmental Exposure - adverse effects | Pregnancy | Animals | Metabolome - drug effects | Carbofuran - adverse effects | Lipid Metabolism - drug effects | Pesticides - adverse effects | Infectious Disease Transmission, Vertical - statistics & numerical data | Nitriles - adverse effects | Metabolomics | Usage | Pesticides | Rattus | Influence | Research | Tricarboxylic acid cycle | Brain | Oxidative stress | Energy metabolism | Carbofuran | Cereals | Nuclear magnetic resonance--NMR | Liver | Amino acids | Insecticides | Glucose | Glyphosate | Glucose metabolism | Herbicides | Toxicology | Mitochondria | Metabolites | Rodents | Lipid metabolism | Urine | Carbohydrates | Liver diseases | Carbohydrate metabolism | Exposure | Pharmacology | Metabolism | Contamination | Molecular chains | Studies | Progeny | Offspring | Acetochlor | Imidacloprid | Females | Energy storage | Index Medicus | Life Sciences | Santé publique et épidémiologie | Nuclear magnetic resonance | NMR
Journal Article
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39
Summary Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge. Our aim was to compare... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Double-Blind Method | Drug Administration Schedule | Thiophenes - adverse effects | Humans | Middle Aged | Morpholines - administration & dosage | Arthroplasty, Replacement, Hip | Male | Thiophenes - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Health care | Medical imaging | Hospitals | Protease inhibitors | Surgery | Tomography | Joint surgery | Drug therapy | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Thiophenes/administration & dosage/adverse effects/therapeutic use | use | Arthroplasty | Replacement | Venous Thromboembolism/prevention & control | Morpholines/administration & dosage/adverse effects/therapeutic use | Kirurgi | Hip | 80 and over | Enoxaparin/administration & dosage/adverse effects/therapeutic use | Fibrinolytic Agents/administration & dosage/adverse effects/therapeutic
Journal Article